ORBIMED ADVISORS LLC Insider Trading $KALA Kala Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

ORBIMED ADVISORS LLC in Kala Pharmaceuticals, Inc.

Trading Symbol: KALA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 3,422,840 shares
Latest Transaction: Feb 06 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Kala Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 06 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.7337,840557,3833,422,8403.4 M to 3.4 M (+1.12 %)
Feb 02 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9922,840342,3723,385,0003.4 M to 3.4 M (+0.68 %)
Feb 02 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00339,4005,091,0003,362,1603 M to 3.4 M (+11.23 %)
Jan 30 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9950,000749,5003,022,7603 M to 3 M (+1.68 %)
Jan 30 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9322,760339,8072,972,7603 M to 3 M (+0.77 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9164,637963,7382,950,0002.9 M to 3 M (+2.24 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.994,36365,4012,885,3632.9 M to 2.9 M (+0.15 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9875,0001,123,5002,881,0002.8 M to 2.9 M (+2.67 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9574,9311,120,2182,806,0002.7 M to 2.8 M (+2.74 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.5038,354556,1332,731,0692.7 M to 2.7 M (+1.42 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9164,637963,7382,950,0002.9 M to 3 M (+2.24 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.994,36365,4012,885,3632.9 M to 2.9 M (+0.15 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9875,0001,123,5002,881,0002.8 M to 2.9 M (+2.67 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9574,9311,120,2182,806,0002.7 M to 2.8 M (+2.74 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.5038,354556,1332,731,0692.7 M to 2.7 M (+1.42 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.4028,446438,0682,692,7152.7 M to 2.7 M (+1.07 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP13.6541,700569,2052,664,2692.6 M to 2.7 M (+1.59 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP12.83170,3382,185,4372,622,5692.5 M to 2.6 M (+6.95 %)
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.0010,707,98500
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00319,3334,789,9952,375,2792.1 M to 2.4 M (+15.53 %)
Jul 27 2017KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyC0.002,055,94602,055,9460 to 2.1 M

Page:   1